PTC
HRMY icon

Private Trust Company’s Harmony Biosciences HRMY Stock Holding History

Private Trust Company’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-45
Closed -$1.24K – 2597
2025
Q3 		$1.24K Hold
45
– – ﹤0.01% 2413
2025
Q2 		$1.42K Buy
+45
New +$1.45K ﹤0.01% 2327
2023
Q4 		– Sell
-80
Closed -$2.62K – 2358
2023
Q3 		$2.62K Hold
80
– – ﹤0.01% 2066
2023
Q2 		$2.81K Buy
80
+18
+29% +$621 ﹤0.01% 2044
2023
Q1 		$2.02K Buy
62
+31
+100% +$1.41K ﹤0.01% 2081
2022
Q4 		$2K Buy
+31
New +$1.7K ﹤0.01% 2014

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Private Trust Company's HRMY Position: Q4 2025 in Review

Private Trust Company sold out of Harmony Biosciences (HRMY) in Q4 2025, closing a stake of 45 shares — an estimated $1.24K sold.

Private Trust Company first reported a position in HRMY in Q4 2022 and held it in 6 quarters. The position peaked at $2.81K in Q2 2023. 325 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

  • Private Trust Company reported no remaining Harmony Biosciences position as of Q4 2025 after selling out during the quarter.
  • Private Trust Company sold 45 Harmony Biosciences shares in Q4 2025, an estimated $1.24K.
  • Private Trust Company first reported a position in Harmony Biosciences in Q4 2022 and held it in 6 quarters.
  • Private Trust Company's Harmony Biosciences position peaked at $2.81K in Q2 2023.
  • 325 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on Private Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.